Results 241 to 250 of about 685,376 (295)
Evaluating Harm Reduction Advice From Large Language Models
Drug and Alcohol Review, Volume 45, Issue 7, November 2026.ABSTRACT Introduction Large language models (LLM) and generative Artificial Intelligence are increasingly providing health information. We have applied a novel method to evaluate the harm reduction information generated by popular LLMs. We focused on the filtration of oral medications for injection and the availability of local harm reduction services.
Khy Choo +3 more
wiley +1 more source
Pulmonary surfactant impacts in vitro activity of selected antifungal drugs against Candida krusei and Candida albicans. [PDF]
Eur J Clin Microbiol Infect DisNussbaumer-Pröll A +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Pulmonary surfactant and tuberculosis
Tuberculosis, 2009Mycobacterium tuberculosis comes in contact with pulmonary surfactant, alveolar macrophages and type II epithelial cells. Alveolar type II epithelial cells secrete pulmonary surfactant, a complex mixture of phospholipids and proteins lining the alveolar surface, while alveolar macrophages are involved in surfactant catabolism.
Zissis C Chroneos +1 more
exaly +3 more sources
ACS Nano, 2013 Interaction with the pulmonary surfactant film, being the first line of host defense, represents the initial bio-nano interaction in the lungs. Such interaction determines the fate of the inhaled nanoparticles and their potential therapeutic or ...
Xinghua Shi, Guoqing Hu, Yi Y. Zuo
exaly +2 more sources
New England Journal of Medicine, 1993
In 1959, not long after surfactant had been identified as critical to maintaining lung inflation at low transpulmonary pressures,1,2 Avery and Mead3 reported that saline extracts from the lungs of preterm infants with respiratory distress syndrome lacked the low surface tension characteristic of pulmonary surfactant. After several unsuccessful attempts
Alan H. Jobe, Alastair J J Wood
exaly +3 more sources
In 1959, not long after surfactant had been identified as critical to maintaining lung inflation at low transpulmonary pressures,1,2 Avery and Mead3 reported that saline extracts from the lungs of preterm infants with respiratory distress syndrome lacked the low surface tension characteristic of pulmonary surfactant. After several unsuccessful attempts
Alan H. Jobe, Alastair J J Wood
exaly +3 more sources
Canadian Journal of Biochemistry and Cell Biology, 1984
The mammalian lung is stabilized by a specialized material, the pulmonary surfactant, which acts by reversibly reducing the surface tension at the air–liquid interface of the lung during breathing. Pulmonary surfactant contains approximately 90% lipid and 10% proteins. Dipalmitoyl phosphatidylcholine, the major lipid component, appears to be primarily
F, Possmayer +3 more
openaire +2 more sources
The mammalian lung is stabilized by a specialized material, the pulmonary surfactant, which acts by reversibly reducing the surface tension at the air–liquid interface of the lung during breathing. Pulmonary surfactant contains approximately 90% lipid and 10% proteins. Dipalmitoyl phosphatidylcholine, the major lipid component, appears to be primarily
F, Possmayer +3 more
openaire +2 more sources
The Pulmonary Surfactant System
Hospital Practice, 1990Surfactant's importance is underscored by the severe morbidity of deficiency states--primary, as in neonatal respiratory distress syndrome, or secondary, as in ARDS. Current knowledge of surfactant synthesis and metabolism is reviewed. Clinically, the effectiveness of exogenous surfactant in RDS has prompted investigation of its administration in ARDS.
S P, Caminiti, S L, Young
openaire +2 more sources
Biomimetic pulmonary surfactants
Life Sciences, 1994Considerable progress has been made in the development of defined mixtures of proteins or peptides with phospholipids which mimic the activity of natural pulmonary surfactants. Several of these biomimetic surfactants are active in animal models and clinical syndromes of surfactant deficiency.
L R, McLean, J E, Lewis
openaire +2 more sources
Pulmonary Surfactant Metabolism
Clinics in Chest Medicine, 1989Recent work suggests that surfactant undergoes a complex sequence of metabolic events during its life cycle in the alveolar airspace. The composition, turnover, and metabolism of surfactant, and the possible "control points" in its metabolic pathway that might be compromised in disease states are discussed.
J R, Wright, S, Hawgood
openaire +2 more sources
Pulmonary Surfactant and Atelectasis
Anesthesiology, 1964Surface activity of atelectatic lung extracts was studied with a surface film balance. All 16 atelectatic specimens demonstrated decreased surface activity regardless of etiology. Of those 12 not associated with pneumonia, contiguous lung tissue was normally surface active. Only atelectatic portions, no matter how tiny, were inactive.
A I, SUTNICK, L A, SOLOFF
openaire +2 more sources